Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company. It engages in the the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.
Company profile
Ticker
CLVLY, CLVLF
Exchange
Website
CEO
Philippe J. Wolgen
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
EpiTan LTD
SEC CIK
CLVLY stock data
Latest filings (excl ownership)
EFFECT
Notice of effectiveness
17 Aug 21
F-6
Registration for ADRs (foreign)
6 Aug 21
424B3
Prospectus supplement
26 Nov 10
424B3
Prospectus supplement
20 Mar 06
SUPPL
Supplemental materials (foreign)
6 May 05
SUPPL
Supplemental materials (foreign)
15 Apr 05
SUPPL
Supplemental materials (foreign)
5 Jan 05
ARS
2004 FY
Annual report to shareholders
5 Oct 04
SUPPL
Supplemental materials (foreign)
5 Oct 04
SUPPL
Supplemental materials (foreign)
23 Aug 04
Latest ownership filings
No filings